These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3047036)

  • 1. Antibodies to translation products of the pre-S1 and pre-S2 regions of the envelope gene of hepatitis B virus in fulminant hepatitis B.
    Ise I; Tsuda F; Aihara S; Machida A; Takai E; Miyamoto H; Akahane Y; Miyakawa Y; Mayumi M
    Hepatology; 1988; 8(5):1089-93. PubMed ID: 3047036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus.
    Takai E; Machida A; Ohnuma H; Miyamoto H; Tanaka T; Baba K; Tsuda F; Usuda S; Nakamura T; Miyakawa Y
    J Immunol Methods; 1986 Dec; 95(1):23-30. PubMed ID: 3537138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biphasic pattern of anti-pre-S responses in acute hepatitis B virus infection.
    Budkowska A; Dubreuil P; Maillard P; Poynard T; Pillot J
    Hepatology; 1990 Dec; 12(6):1271-7. PubMed ID: 2258143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of pre-S2 antigen and antibody in fulminant hepatitis B. Evidence for heterogeneous serological responses.
    Brahm J; Fagan EA; Budkowska A; Dubreuil P; Smith H; Pillot J; Williams R
    J Hepatol; 1991 Jul; 13(1):49-55. PubMed ID: 1918878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for the study of pre-S proteins of hepatitis B virus and their antibodies: pathogenetic and clinical implications.
    Alberti A; Pontisso P; Milanesi G
    Ric Clin Lab; 1988; 18(2-3):241-58. PubMed ID: 3062749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of pre-S1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen.
    Budkowska A; Dubreuil P; Gerlich WH; Lazizi Y; Pillot J
    J Med Virol; 1988 Oct; 26(2):217-25. PubMed ID: 2460586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of anti-pre-S antibodies in patients with fulminant hepatic failure.
    Irshad M; Gandhi BM; Acharya SK; Joshi YK; Tandon BN
    Gastroenterol Jpn; 1990 Aug; 25(4):499-502. PubMed ID: 2210226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection.
    Klinkert MQ; Theilmann L; Pfaff E; Schaller H
    J Virol; 1986 May; 58(2):522-5. PubMed ID: 3701922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-pre-S antibodies in different groups of patients with hepatitis B virus infection.
    Irshad M; Gandhi BM; Acharya SK; Joshi YK; Tandon BN
    J Gastroenterol Hepatol; 1989; 4(1):25-32. PubMed ID: 2490940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and significance of anti-pre S2 in patients with hepatitis B and HBsAg carriers].
    Ding Z
    Zhonghua Yi Xue Za Zhi; 1990 Nov; 70(11):611-4, 42. PubMed ID: 1963350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
    Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
    Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of pre-S1 and pre-S2 in relation to HBsAg expression.
    Yuki N; Hayashi N; Katayama K; Kasahara A; Ueda K; Fusamoto H; Sato N; Kamada T
    Hepatology; 1990 Jan; 11(1):38-43. PubMed ID: 2295469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase.
    Brahm J; Vento S; Rondanelli EG; Ranieri S; Fagan EA; Williams R; Eddleston AL
    J Med Virol; 1988 Feb; 24(2):205-9. PubMed ID: 3351487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of human hepatitis B virus P-gene derived proteins.
    Weimer T; Weimer K; Tu ZX; Jung MC; Pape GR; Will H
    J Immunol; 1989 Dec; 143(11):3750-6. PubMed ID: 2584717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H; Inoue T; Tsuda F; Okamoto H; Akahane Y
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection.
    Suga M; Arima K; Yachi A
    Digestion; 1991; 50(3-4):153-61. PubMed ID: 1812042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-S proteins in hepatitis B.
    Kuijpers L; Koens M; Murray-Lyon I; Coleman JC; Karayiannis P; Thomas HC; Zanetti A; Cargnel A; Harrison TJ; Zuckerman AJ
    J Med Virol; 1989 May; 28(1):47-51. PubMed ID: 2723617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B pre-S1 and pre-S2 proteins: clinical significance and relation to hepatitis B virus DNA.
    van Ditzhuijsen TJ; Kuijpers LP; Koens MJ; Rijntjes PJ; van Loon AM; Yap SH
    J Med Virol; 1990 Oct; 32(2):87-91. PubMed ID: 2280257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
    Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T
    Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.